Tribunal upholds CIT(A)'s order on 5% markup for clinical trials, deeming assessee a coordinator.

The Tribunal upheld the CIT(A)'s order, determining that the 5% markup charged by the assessee for clinical trial services was justified. It was concluded that the assessee's role was that of a coordinator/facilitator rather than a service provider, and its profits were exempt under section 10B. As a result, the Tribunal dismissed the department's appeals, ruling in favor of the assessee.

---

---

Issues Involved:
1. Adjustment of Rs. 16,23,251 in relation to international transaction under section 92CA(3) of the Income-tax Act.
2. Determination of arm's length price for clinical trial services provided by the assessee.
3. Comparison of the assessee's functions with other clinical trial service providers and technical service providers.
4. Examination of the appropriateness of the Transactional Net Margin Method (TNMM) adopted by the assessee.
5. Justification of the 5% markup charged by the assessee over costs incurred.

Issue-wise Detailed Analysis:

1. Adjustment of Rs. 16,23,251 in relation to international transaction under section 92CA(3) of the Income-tax Act:
The Assessing Officer made an adjustment of Rs. 16,23,251 because the fees charged by the assessee-company for clinical trial services were less than 95% of the arm's length price determined under section 92CA(3). The Transfer Pricing Officer (TPO) determined the arm's length price for the services at Rs. 1,18,50,108, leading to an adjustment of Rs. 16,23,251. The CIT(A) held that the adjustment made by the TPO was unjustified, which led to the department's appeal.

2. Determination of arm's length price for clinical trial services provided by the assessee:
The assessee, a joint venture between Cadila Healthcare Ltd. and Byk Gulden Lomberg GmbH Germany, provided clinical research services on new molecules. The TPO concluded that the clinical trial services were in the nature of services for which an independent third party would pay, and thus, the markup of 5% over cost was not at arm's length. The TPO compared the assessee's services with those of other clinical trial service providers and determined a markup of 17.14%.

3. Comparison of the assessee's functions with other clinical trial service providers and technical service providers:
The TPO compared the assessee's functions with three clinical trial service providers: Quintiles Spectral India (P.) Ltd., SIRO Clinpharm Pvt. Ltd., and Neeman International Asia Ltd. The TPO also considered other service providers in the skilled industry, such as NIS Sparts Ltd., Vimta Labs Ltd., and Water & Power Consultancy Services India Ltd. The TPO concluded that the average operating profit margin of 18.38% should be applied, but chose the lesser margin of 17.14% for benchmarking the international transactions.

4. Examination of the appropriateness of the Transactional Net Margin Method (TNMM) adopted by the assessee:
The assessee adopted TNMM to show that the transactions with Associated Enterprises were at arm's length. The CIT(A) noted that the assessee provided low-end support services and was not well-equipped or authorized to undertake clinical trial activities in India. The CIT(A) concluded that the comparables selected by the TPO were not appropriate without necessary adjustments.

5. Justification of the 5% markup charged by the assessee over costs incurred:
The CIT(A) observed that the assessee's role was mainly limited to facilitation and coordination between BGL and third-party agencies/hospitals. The CIT(A) noted that the assessee did not have the necessary infrastructure and specialized facilities to undertake clinical trial activities. The CIT(A) concluded that the 5% markup charged by the assessee was justified, considering the nature of the services provided and the lack of infrastructure for conducting full-fledged clinical trials.

Conclusion:
The Tribunal upheld the CIT(A)'s order, concluding that the 5% markup charged by the assessee was justified and did not call for any adjustment. The Tribunal noted that the assessee's functions were more like a coordinator/facilitator rather than performing the function itself. The Tribunal also considered that the assessee's profits were exempt under section 10B, and there was no necessity for the assessee to transfer profits to any overseas jurisdiction. Therefore, the Tribunal dismissed the department's appeals.

---